Results 101 to 110 of about 49,774 (199)

Francisella tularensis Transmission by Solid Organ Transplantation, 20171. [PDF]

, 2019
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died.
Annambhotla, Pallavi, Asad, Shadaba, Aslam, Saima, Basavaraju, Sridhar V, Brown, Jennifer, Burns, Kevin, Carifo, Karen, Dagher, Hikmat N, Fritz, Curtis L, Gonzalez, Anthony, Ham, John, Helsel, Elizabeth, Hinckley, Alison F, Iser, Joseph, Johnson, Michael, Jones, Jefferson M, Kelley, Walter E, Kingry, Luke C, Krafft, Melissa, Kwit, Natalie A, Medina-Garcia, Luis H, Mohler, Kelli, Murua, Christian, Nelson, Christina A, Petersen, Jeannine M, Respicio-Kingry, Laurel, Tularemia in Transplant Recipients Investigation Team, Wiggins, Landon, Zhang, Ying   +28 more
core  

Involvement of the blaCTX-M-3 gene in emergence of a peculiar resistance phenotype in Klebsiella pneumoniae

Frontiers in Cellular and Infection Microbiology
IntroductionThis study aimed to investigate the mechanism underlying a peculiar resistance phenotype in Klebsiella pneumoniae, characterized by reduced susceptibility to cefepime compared to ceftazidime.MethodsAntimicrobial susceptibility testing ...
Peishan Li, Leping Yan, Jingjie Song, Chengfeng Lin, Fangyin Zeng, Shihan Zeng   +5 more
doaj   +1 more source

The Nephrotoxicity of Vancomycin. [PDF]

, 2017
Farber, John L., Filippone, Edward J., Kraft, Walter K.   +2 more
core   +2 more sources

Cefepime versus carbapenem for treating complicated urinary tract infection caused by cefoxitin-nonsusceptible ESCPM organisms: a multicenter, real-world study

BMC Infectious Diseases
Background This investigation aimed to compare the efficacy of cefepime and carbapenem for complicated urinary tract infection (cUTI) caused by presumptive AmpC β-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii ...
Liang Chen, Jie Hua, Xiaopu He
doaj   +1 more source

Risk of Potentially Neurotoxic Exposure in Infants Under High-Dose Cefepime Treatment—A Pharmacometric Simulation Study

Pharmaceutics
Background: Optimal dosing of cefepime in infants 1–2 months remains undefined. Objectives: We aimed to quantify the risk of potentially neurotoxic exposure with high-dose cefepime (50 mg/kg/8 h) in infants 1–2 months of age, as compared to adjacent age ...
Verena Gotta, Chantal Csajka, Antonia Glauser, Christoph Berger, Marc Pfister, Paolo Paioni   +5 more
doaj   +1 more source

Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins [PDF]

, 2017
Zwitterionic 7-methoxyimino cephalosporins (cefpirome, cefepime, cefclidin, DQ2556, FKO37 and SCE2787) possess a variable substitution at C3 which contains a quarernary nitrogen.
Neu, H., Pechère, J. C., Wilson, W.
core  

Empiric antibiotics for sepsis [PDF]

, 2018
Buckman, Sara A, Mazuski, John E, Turnbull, Isaiah R   +2 more
core   +2 more sources

Comparison of clinical outcomes of treatment with cefepime monotherapy vs. amikacin-ceftriaxone combination in children with chemotherapy-induced fever and neutropenia [PDF]

Journal of Research in Applied and Basic Medical Sciences
Background & Aims: Fever and neutropenia are major causes of mortality in cancer patients. This study compares the effectiveness of cefepime monotherapy with a ceftriaxone–amikacin combination in treating these complications.
Zahra Ghelichkhan, Sarah Mohsenzadeh, Mehran Noroozi, Farid Ghazizadeh   +3 more
doaj  

Prediction of Antibiotic Influence by Presence of Some β-lactamase Gene in AcinetobacterInfected Patients Hospitalized in Tehran, Iran [PDF]

Acinetobacter baumannii which is gram-negative rod and infecting hospitalized patient often develops multiple drug resistance patterns and causes serious problem in treatment.
آقابزرگی, سهراب, امانی, فیروز, اکبری, مهدی, دادگر پاکدل, جواد, دادگر پاکدل, فاطمه, رسولی, ایرج, نیاکان, محمد, کاظمی, سهیلا, یادگاری نیا, داوود   +8 more
core  

A Pilot Study of Cefepime and Meropenem Therapeutic Drug Monitoring in Pediatric Patients on Extracorporeal Therapy. [PDF]

J Pediatr Pharmacol Ther
McFarland KM, Smith CJ, Karwande S, Brothers AW.   +3 more
europepmc   +1 more source